InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: cabel post# 211268

Wednesday, 01/03/2018 6:00:35 PM

Wednesday, January 03, 2018 6:00:35 PM

Post# of 402948
Time will tell, but recently Onxeo granted world wide rights to Monopar Therapeutics for Validive(to treat SOM in head and neck cancer patients). From Onxeo 9/13/17 pr: Agreement includes substantial milestone payments up to $108m as well as escalating royalties on future sales Monopar Therapeutics will drive and fund all remaining development, regulatory and commercialization activities.

We shall see.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News